Published on in Vol 5, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30239, first published .
Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study

Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study

Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study

Journals

  1. Versteegden D, van Himbeeck M, Burghoorn A, Lovei P, Deckers E, Jansen J, Nienhuijs S. The Value of Tracking Data on the Behavior of Patients Who Have Undergone Bariatric Surgery: Explorative Study. JMIR Formative Research 2022;6(5):e27389 View
  2. Moein H, Arteaga E, Sarkar S. Using Telehealth for Diagnosis and Management of Non‐Alcoholic Fatty Liver Disease. Clinical Liver Disease 2022;19(4):171 View
  3. Stine J, Rivas G, Hummer B, Duarte-Rojo A, May C, Geyer N, Chinchilli V, Conroy D, Mitchell E, McCallum M, Michealides A, Schmitz K. Mobile health lifestyle intervention program leads to clinically significant loss of body weight in patients with NASH. Hepatology Communications 2023;7(4) View
  4. Rosenlund M, Kinnunen U, Saranto K. The Use of Digital Health Services Among Patients and Citizens Living at Home: Scoping Review. Journal of Medical Internet Research 2023;25:e44711 View
  5. Stine J, Long M, Corey K, Sallis R, Allen A, Armstrong M, Conroy D, Cuthbertson D, Duarte-Rojo A, Hallsworth K, Hickman I, Kappus M, Keating S, Pugh C, Rotman Y, Simon T, Vilar-Gomez E, Wong V, Schmitz K. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatology Communications 2023;7(4) View
  6. Guarino M, Cossiga V, Cutolo F, Attanasio M, Lieto R, Morisco F. COVID-19 and Fatty Liver Disorders. Journal of Clinical Medicine 2023;12(13):4316 View
  7. STINE J, LONG M, COREY K, SALLIS R, ALLEN A, ARMSTRONG M, CONROY D, CUTHBERTSON D, DUARTE-ROJO A, HALLSWORTH K, HICKMAN I, KAPPUS M, KEATING S, PUGH C, ROTMAN Y, SIMON T, VILAR-GOMEZ E, WONG V, SCHMITZ K. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Medicine & Science in Sports & Exercise 2023;55(9):1717 View
  8. Capuano P, Hileman B, Tigano S, Magro B, Lo Re V, Liotta R, Sciveres M, Ranucci G, Provenzani A, Burgio G, Scardulla C, Arcadipane A, Martucci G. Telemedicine in Patients Affected by Chronic Liver Disease: A Scoping Review of Clinical Outcomes and the Devices Evaluated. Journal of Clinical Medicine 2023;12(15):5128 View
  9. Younossi Z, Henry L. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action. Diabetes Spectrum 2024;37(1):9 View
  10. Freer C, George E, Tan S, Abbott G, Daly R. Delivery of a telehealth supported home exercise program with dietary advice to increase plant-based protein intake in people with non-alcoholic fatty liver disease: a 12-week randomised controlled feasibility trial. British Journal of Nutrition 2024:1 View
  11. Akbar F, Choirida S, Muttaqin A, Ekayanti F, Nisa H, Hendarto H. Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 2024;14(3):281 View